OncoLens Connects Cancer Programs and Life Science Organizations to Increase Guideline Based Biomarker and Targeted Treatment Therapies

Case Study

Broad Based NGS Testing and Targeted Therapies in Multidisciplinary Care Teams (MDT)

In a Life Science company sponsored Quality Improvement Project, OncoLens brought together an NCI center, a regional IDN, and a community cancer center to assess the current practices and insights into local barriers to testing.

The project subsequently addressed these barriers resulting in the overall improvement of NGS testing and targeted therapies in solid tumors possessing a rare gene fusion.

Complete our quick form to download and read the full case study.